the-future-now:

An Ebola vaccine could hit the market in 2018

• An experimental Ebola vaccine was shown to provide 100% protection against the deadly disease, according to a new study in the Lancet.
• The vaccine, manufactured by Merck and
  tested in a large trial study in Guinea, appears to be a major
  breakthrough in preventing the virus.
• Ebola left more than 11,000 people
  in West Africa and a handful of other countries dead during an outbreak that began in 2014. Read more

follow @the-future-now​